Advertisement
Filtered cigarettes might be even more unhealthy than unfiltered ones

Filtered Cigarettes May Up Rates of Lung Adenocarcinoma

0
Design of cigarette filters with ventilation implicated in rising rates
For patients with relapsing-remitting multiple sclerosis

Enhanced Atypical Lymphocytes in Natalizumab-Treated MS

0
Enhanced fraction of atypical lymphocytes, especially binucleated and plasmacytoid lymphocytes
Exercising regularly

Even Small Amounts of Alcohol Can Affect Breast Cancer Risk

0
Small glass of wine each day can up odds of both premenopausal and postmenopausal breast cancer
Older black Americans are more likely than whites to develop interval colorectal cancer

Risk for Interval CRC Higher in Blacks Than Whites

0
Differences most pronounced for cancer of the distal colon and the rectum
For patients undergoing blood cultures in an emergency department setting

Initial Specimen Diversion Device Cuts Culture Contamination

0
Initial specimen diversion device reduces blood culture contamination without impacting sensitivity
Patients with life-limiting illness often receive medications of questionable benefit given their remaining life span

Patients Often Prescribed Futile Drugs in Last Months of Life

0
Researchers find many still prescribed long-term disease-preventing medications
Overweight boys may be more likely to develop colon cancer later in life

Overweight Boys at Greater Risk of Colon Cancer in Adulthood

0
But study also found that losing weight lowered those odds
Testing for combined urinary PCA3 and TMPRSS2:ERG RNA can improve detection of prostate cancer

Combined Urine Test for T2:ERG, PCA3 Ups Prostate CA Detection

0
Combined urinary testing can avoid unnecessary prostate biopsy, while preserving high sensitivity
Capecitabine (Xeloda) may prolong survival in patients with biliary tract cancer

ASCO: Capecitabine May Extend Survival in Biliary Tract Cancer

0
Survival benefit seen in those given capecitabine versus surgery alone
Use of phosphodiesterase type 5 inhibitors does not appear to increase the risk of melanoma

Researchers Say PDE5 Inhibitors Don’t Cause Melanoma

0
Any connection appears to be due to detection bias, investigators conclude